Treatment of vitamin K deficiency in hemodialysis patients – A pilot study comparing menaquinone-7 tablets and a vitamin K rich diet

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Treatment of vitamin K deficiency in hemodialysis patients – A pilot study comparing menaquinone-7 tablets and a vitamin K rich diet. / Lentz, Katrine Aagaard; Vahlgren, Julie; Hansen, Ditte; Plebani, Mario; Fusaro, Maria; Rasmussen, Lars Melholt; Jakobsen, Jette; Sloth, Jens Jørgen; Hansen, Henrik Post; Andersen, Jens Rikardt.

I: International Journal of Nephrology and Renovascular Disease, Bind 15, 2022, s. 267-276.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Lentz, KA, Vahlgren, J, Hansen, D, Plebani, M, Fusaro, M, Rasmussen, LM, Jakobsen, J, Sloth, JJ, Hansen, HP & Andersen, JR 2022, 'Treatment of vitamin K deficiency in hemodialysis patients – A pilot study comparing menaquinone-7 tablets and a vitamin K rich diet', International Journal of Nephrology and Renovascular Disease, bind 15, s. 267-276. https://doi.org/10.2147/IJNRD.S365912

APA

Lentz, K. A., Vahlgren, J., Hansen, D., Plebani, M., Fusaro, M., Rasmussen, L. M., Jakobsen, J., Sloth, J. J., Hansen, H. P., & Andersen, J. R. (2022). Treatment of vitamin K deficiency in hemodialysis patients – A pilot study comparing menaquinone-7 tablets and a vitamin K rich diet. International Journal of Nephrology and Renovascular Disease, 15, 267-276. https://doi.org/10.2147/IJNRD.S365912

Vancouver

Lentz KA, Vahlgren J, Hansen D, Plebani M, Fusaro M, Rasmussen LM o.a. Treatment of vitamin K deficiency in hemodialysis patients – A pilot study comparing menaquinone-7 tablets and a vitamin K rich diet. International Journal of Nephrology and Renovascular Disease. 2022;15:267-276. https://doi.org/10.2147/IJNRD.S365912

Author

Lentz, Katrine Aagaard ; Vahlgren, Julie ; Hansen, Ditte ; Plebani, Mario ; Fusaro, Maria ; Rasmussen, Lars Melholt ; Jakobsen, Jette ; Sloth, Jens Jørgen ; Hansen, Henrik Post ; Andersen, Jens Rikardt. / Treatment of vitamin K deficiency in hemodialysis patients – A pilot study comparing menaquinone-7 tablets and a vitamin K rich diet. I: International Journal of Nephrology and Renovascular Disease. 2022 ; Bind 15. s. 267-276.

Bibtex

@article{9475946111e14dd0a4757dc398e62b78,
title = "Treatment of vitamin K deficiency in hemodialysis patients – A pilot study comparing menaquinone-7 tablets and a vitamin K rich diet",
abstract = "Purpose: Vitamin K deficiency and hence a high level of plasma dephosphorylated undercarboxylated matrix Gla protein (dp-ucMGP) is frequent in patients on hemodialysis. This group is recommended to restrict their potassium intake which often leads to restriction of vitamin K rich foods. A menaquinone-7 (MK-7) supplement has been shown to decrease dp-ucMGP, but it has yet to be examined if a vitamin K rich diet could be equally effective.Patients and Methods: A prospective randomized crossover intervention trial with two arms; 6 weeks of 360 μg MK-7 tablet/day and 6 weeks of a vitamin K rich diet with a 3-week washout period in between. Participants were 10 patients in hemodialysis and the primary outcome measures were changes in dp-ucMGP, total MGP (tMGP), and undercarboxylated osteocalcin (ucOC). Furthermore, the level of potassium and phylloquinone in broccoli was determined after different durations of boiling. Results: During the MK-7 intervention the dp-ucMGP and ucOC decreased significantly compared to baseline (−0.42 [−0.93; −0.22] nmol/L (p=<0.01) and −1.85 [−2.91; −1.30] nmol/L (p<0.01)), while these were unchanged during the dietary intervention (0.03 [−0.64; 0.37] nmol/L (p=1.00) and 0.30 [−1.71; 1.41] nmol/L (p=0.77)). Between the two interventions there was a greater decrease in ucOC (p=0.02) during the MK-7 compared to the dietary period. No significant changes in the total MGP levels were found in any of the periods. The retention of potassium following boiling for 2 minutes and 8 minutes was 76% and 49%, respectively, while for phylloquinone the retention was 92%, and independent of duration of boiling. Conclusion: A daily MK-7 supplement for 6 weeks lowered dp-ucMGP and ucOC significantly, while a vitamin K rich diet was not able to induce any significant effect. Boiled broccoli maintains a reasonable content of phylloquinone while potassium is extracted and is a reasonable source of phylloquinone for patients on hemodialysis.",
keywords = "Hemodialysis, Menaquinone, Nutrition, Phylloquinone",
author = "Lentz, {Katrine Aagaard} and Julie Vahlgren and Ditte Hansen and Mario Plebani and Maria Fusaro and Rasmussen, {Lars Melholt} and Jette Jakobsen and Sloth, {Jens J{\o}rgen} and Hansen, {Henrik Post} and Andersen, {Jens Rikardt}",
note = "Publisher Copyright: {\textcopyright} 2022 Lentz et al.",
year = "2022",
doi = "10.2147/IJNRD.S365912",
language = "English",
volume = "15",
pages = "267--276",
journal = "International Journal of Nephrology and Renovascular Disease",
issn = "1178-7058",
publisher = "Dove Medical Press Ltd",

}

RIS

TY - JOUR

T1 - Treatment of vitamin K deficiency in hemodialysis patients – A pilot study comparing menaquinone-7 tablets and a vitamin K rich diet

AU - Lentz, Katrine Aagaard

AU - Vahlgren, Julie

AU - Hansen, Ditte

AU - Plebani, Mario

AU - Fusaro, Maria

AU - Rasmussen, Lars Melholt

AU - Jakobsen, Jette

AU - Sloth, Jens Jørgen

AU - Hansen, Henrik Post

AU - Andersen, Jens Rikardt

N1 - Publisher Copyright: © 2022 Lentz et al.

PY - 2022

Y1 - 2022

N2 - Purpose: Vitamin K deficiency and hence a high level of plasma dephosphorylated undercarboxylated matrix Gla protein (dp-ucMGP) is frequent in patients on hemodialysis. This group is recommended to restrict their potassium intake which often leads to restriction of vitamin K rich foods. A menaquinone-7 (MK-7) supplement has been shown to decrease dp-ucMGP, but it has yet to be examined if a vitamin K rich diet could be equally effective.Patients and Methods: A prospective randomized crossover intervention trial with two arms; 6 weeks of 360 μg MK-7 tablet/day and 6 weeks of a vitamin K rich diet with a 3-week washout period in between. Participants were 10 patients in hemodialysis and the primary outcome measures were changes in dp-ucMGP, total MGP (tMGP), and undercarboxylated osteocalcin (ucOC). Furthermore, the level of potassium and phylloquinone in broccoli was determined after different durations of boiling. Results: During the MK-7 intervention the dp-ucMGP and ucOC decreased significantly compared to baseline (−0.42 [−0.93; −0.22] nmol/L (p=<0.01) and −1.85 [−2.91; −1.30] nmol/L (p<0.01)), while these were unchanged during the dietary intervention (0.03 [−0.64; 0.37] nmol/L (p=1.00) and 0.30 [−1.71; 1.41] nmol/L (p=0.77)). Between the two interventions there was a greater decrease in ucOC (p=0.02) during the MK-7 compared to the dietary period. No significant changes in the total MGP levels were found in any of the periods. The retention of potassium following boiling for 2 minutes and 8 minutes was 76% and 49%, respectively, while for phylloquinone the retention was 92%, and independent of duration of boiling. Conclusion: A daily MK-7 supplement for 6 weeks lowered dp-ucMGP and ucOC significantly, while a vitamin K rich diet was not able to induce any significant effect. Boiled broccoli maintains a reasonable content of phylloquinone while potassium is extracted and is a reasonable source of phylloquinone for patients on hemodialysis.

AB - Purpose: Vitamin K deficiency and hence a high level of plasma dephosphorylated undercarboxylated matrix Gla protein (dp-ucMGP) is frequent in patients on hemodialysis. This group is recommended to restrict their potassium intake which often leads to restriction of vitamin K rich foods. A menaquinone-7 (MK-7) supplement has been shown to decrease dp-ucMGP, but it has yet to be examined if a vitamin K rich diet could be equally effective.Patients and Methods: A prospective randomized crossover intervention trial with two arms; 6 weeks of 360 μg MK-7 tablet/day and 6 weeks of a vitamin K rich diet with a 3-week washout period in between. Participants were 10 patients in hemodialysis and the primary outcome measures were changes in dp-ucMGP, total MGP (tMGP), and undercarboxylated osteocalcin (ucOC). Furthermore, the level of potassium and phylloquinone in broccoli was determined after different durations of boiling. Results: During the MK-7 intervention the dp-ucMGP and ucOC decreased significantly compared to baseline (−0.42 [−0.93; −0.22] nmol/L (p=<0.01) and −1.85 [−2.91; −1.30] nmol/L (p<0.01)), while these were unchanged during the dietary intervention (0.03 [−0.64; 0.37] nmol/L (p=1.00) and 0.30 [−1.71; 1.41] nmol/L (p=0.77)). Between the two interventions there was a greater decrease in ucOC (p=0.02) during the MK-7 compared to the dietary period. No significant changes in the total MGP levels were found in any of the periods. The retention of potassium following boiling for 2 minutes and 8 minutes was 76% and 49%, respectively, while for phylloquinone the retention was 92%, and independent of duration of boiling. Conclusion: A daily MK-7 supplement for 6 weeks lowered dp-ucMGP and ucOC significantly, while a vitamin K rich diet was not able to induce any significant effect. Boiled broccoli maintains a reasonable content of phylloquinone while potassium is extracted and is a reasonable source of phylloquinone for patients on hemodialysis.

KW - Hemodialysis

KW - Menaquinone

KW - Nutrition

KW - Phylloquinone

U2 - 10.2147/IJNRD.S365912

DO - 10.2147/IJNRD.S365912

M3 - Journal article

C2 - 36277743

AN - SCOPUS:85139951874

VL - 15

SP - 267

EP - 276

JO - International Journal of Nephrology and Renovascular Disease

JF - International Journal of Nephrology and Renovascular Disease

SN - 1178-7058

ER -

ID: 323468603